SPIRE1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62458935193399E-12 |
Normal-vs-Stage2 |
5.79050000000247E-05 |
Normal-vs-Stage3 |
1.32140000053127E-08 |
Normal-vs-Stage4 |
6.10770000000205E-05 |
Stage1-vs-Stage2 |
8.425600E-01 |
Stage1-vs-Stage3 |
1.951170E-01 |
Stage1-vs-Stage4 |
5.744500E-03 |
Stage2-vs-Stage3 |
5.448800E-01 |
Stage2-vs-Stage4 |
1.142040E-01 |
Stage3-vs-Stage4 |
1.589410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
1.084360E-02 |
Normal-vs-Asian |
1.449990E-01 |
Caucasian-vs-AfricanAmerican |
1.81223999999869E-05 |
Caucasian-vs-Asian |
5.212000E-01 |
AfricanAmerican-vs-Asian |
3.922000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
4.66293670342566E-15 |
Male-vs-Female |
2.460800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.148300E-02 |
Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(81-100Yrs) |
1.990130E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.299300E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.680600E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.633230E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.794000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.959000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.910000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.004300E-03 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
4.32209823486573E-13 |
Normal-vs-Grade 4 |
6.816400E-03 |
Grade 1-vs-Grade 2 |
3.729800E-01 |
Grade 1-vs-Grade 3 |
4.975900E-02 |
Grade 1-vs-Grade 4 |
1.961890E-03 |
Grade 2-vs-Grade 3 |
1.318110E-02 |
Grade 2-vs-Grade 4 |
1.67365999999003E-05 |
Grade 3-vs-Grade 4 |
1.534370E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
2.23559999956713E-07 |
ccA subtype-vs-ccB subtype |
7.41369999945896E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62481139653892E-12 |
Normal-vs-N1 |
9.378400E-02 |
N0-vs-N1 |
2.979600E-01 |
|
|